Boundless Bio Inc (BOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | |
| Operating Expenses | 26,726 | 10,950 |
| Operating Income | -26,726 | -10,950 |
| Other Income | 268 | 131 |
| Pre-tax Income | -26,458 | -10,819 |
| Net Income Continuous | -26,458 | -10,819 |
| Net Income | $-26,458 | $-10,819 |
| EPS Basic Total Ops | -23.03 | -21.56 |
| EPS Basic Continuous Ops | -23.03 | -21.55 |
| EPS Diluted Total Ops | -23.03 | -21.56 |
| EPS Diluted Continuous Ops | -23.03 | -21.55 |
| EBITDA(a) | $-25,764 | $-10,915 |